Related Experiment Video
Updated: Mar 18, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
COPART Risk Score, Endothelial Dysfunction, and Arterial Hypertension are Independent Risk Factors for Mortality in
1Department of Internal Medicine, Division of Angiology, Medical University Graz, Austria.
Insights
The COPART risk score and flow-mediated dilation (FMD) predict mortality in peripheral artery disease patients. Combining these with arterial hypertension offers the best long-term survival assessment for claudicants.
Area of Science:
- Vascular Medicine
- Cardiovascular Research
- Clinical Prognostics
Background:
- Peripheral artery disease (PAOD) significantly impacts patient prognosis.
- The COPART risk score is a tool for assessing PAOD patient outcomes.
- Endothelial function, measured by flow-mediated dilation (FMD), is crucial for vascular health.
Purpose of the Study:
- To evaluate the long-term mortality prediction capabilities of the COPART risk score and FMD in patients with intermittent claudication.
- To determine the combined predictive value of these markers for disease-specific survival.
Main Methods:
- A prospective observational study included 184 claudicants with a median follow-up of 7.9 years.
- Brachial FMD was measured at study inclusion to assess endothelial function.
- Patients were stratified into low, medium, and high risk groups based on the COPART risk score.
Main Results:
- Overall survival rates significantly differed across COPART risk score groups (p < .001).
- Survivors exhibited significantly better FMD compared to non-survivors (p < .001).
- COPART risk score, FMD (≤2.5 vs. >2.5), and arterial hypertension were identified as independent predictors of long-term mortality.
Conclusions:
- The COPART risk score, FMD, and arterial hypertension are significant independent predictors of long-term mortality in claudicants.
- Integrating these three factors provides the most accurate mortality assessment for this patient group.
- These findings support the use of a multi-factor approach for predicting long-term outcomes in PAOD.
Objective:
The COPART risk score consists of six variables to assess the prognosis of PAOD patients. The flow mediated dilation (FMD) quantifies endothelial function. The aim of this study was to evaluate the mortality prediction of these two variables in a long-term observation of claudicants.
Methods:
184 consecutive claudicants were included in a prospective observational study over a median observation period of 7.9 (IQR 7.2-8.7) years. The endothelial function was assessed on the day of study inclusion using brachial FMD.
Results:
Three groups were assigned according to the COPART risk score: low risk (LR), n = 72 (39%); medium risk (MR), n = 59 (32%); and high risk (HR), n = 53 (29%). Overall survival rates differed among COPART risk score groups (p < .001, 5 year survival: LR group 83% [95% CI 74-92%]; MR group 73% [95% CI 62-84%]; HR group 57% [95% CI 43-70%]). Survivors had a significantly better median FMD than non-survivors (4.1% [IQR 1.2-6.4] vs. 1.3% [IQR 0.0-4.2]; p < .001). Also the FMD differed significantly among the three COPART risk groups (LR 4.0% [IQR 1.2-6.3], MR 2.3% [IQR 0.0-6.3], HR 1.7% [IQR 0.0-3.6]; p = .033). Finally, independent predictors for disease specific survival were COPART risk score (p = .033; MR group [HR 1.6], 95% CI 0.7-3.6; HR group [HR 2.7], 95% CI 1.2-5.8), FMD (p = .004; FMD ≤2.5 vs. >2.5, HR 2.6, 95% CI 1.4-4.9), and arterial hypertension (p = .039; HR 3.5, 95% CI 1.1-11.3).
Conclusions:
COPART risk score, FMD, and arterial hypertension are independent long-term mortality predictors in this group of claudicants. The best mortality assessment is provided by including all three predictors.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease I: Introduction

